PR Newswire (Mar 28, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
71 people get SHP articles and Market Currents by email alert.
Get email alerts on SHP »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
PR Newswire (Mar 20, 2013)
-
PR Newswire (Feb 25, 2013)
-
-
-
China Biotech In Review: WuXi PharmaTech, PRA Form Clinical CRO JVChinaBio Today • Sun, Dec 23, 2012 -
PR Newswire (Dec 21, 2012)
-
PR Newswire (Nov 20, 2012)
-
PR Newswire (Nov 6, 2012)
-
PR Newswire (Sep 13, 2012)
-
-
PR Newswire (Aug 20, 2012)
-
PR Newswire (Aug 6, 2012)
-
PR Newswire (Aug 3, 2012)
-
PR Newswire (Jul 17, 2012)
-
-
ShangPharma Going PrivateMarkus Aarnio • Mon, Jul 9, 2012 -
PR Newswire (Jul 6, 2012)
-
4 Cash Heavy Small Cap Biotech Stocks Trading Near 52-Week LowsZetaKap • Thu, Jun 14, 2012
-
To learn more about Seeking Alpha Pro, click here.
-
ShangPharma Going PrivateMarkus Aarnio • Mon, Jul 9, 2012
-
ShangPharma Reports 26% Increase in Q1 RevenuesChinaBio Today • Sun, May 22, 2011
-
-
ShangPharma Prices IPO at $15, Plans to Broaden ServicesChinaBio Today • Wed, Oct 20, 2010
-
-
-
China Biotech In Review: WuXi PharmaTech, PRA Form Clinical CRO JVChinaBio Today • Sun, Dec 23, 2012
-
-
-
4 Cash Heavy Small Cap Biotech Stocks Trading Near 52-Week LowsZetaKap • Thu, Jun 14, 2012
-
-
3 Undervalued BRIC Stocks With Strong Hedge Fund BuyingKapitall • Tue, May 8, 2012 -
-
-
Are WuXi PharmaTech and ShangPharma M&A Targets?ChinaBio Today • Thu, Feb 2, 2012
-
-
-
-
-
-
-
-
-
There are no Transcripts on SHP.
-
at MarketWatch.com (May 2, 2013)
-
at MarketWatch.com (May 2, 2013)
-
PR Newswire (Mar 28, 2013)
-
PR Newswire (Mar 20, 2013)
-
at MarketWatch.com (Feb 28, 2013)
-
PR Newswire (Feb 25, 2013)
-
at MarketWatch.com (Feb 14, 2013)
-
at MarketWatch.com (Jan 9, 2013)
-
PR Newswire (Dec 21, 2012)
-
PR Newswire (Nov 20, 2012)
-
PR Newswire (Nov 6, 2012)
-
PR Newswire (Sep 13, 2012)
-
at Fox Business (Aug 28, 2012)
-
PR Newswire (Aug 20, 2012)
-
PR Newswire (Aug 6, 2012)
-
PR Newswire (Aug 3, 2012)
-
PR Newswire (Jul 17, 2012)
-
at MarketWatch.com (Jul 6, 2012)
-
PR Newswire (Jul 6, 2012)
-
at MarketWatch.com (Jun 26, 2012)
SHP vs. ETF Alternatives
Company Description
Currently, there's no company description for SHP.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
-
Friday, December 21, 2012, 9:10 AM
Premarket gainers: HALO +19%. CEMI +17%. ASCA +17%. APPY +14%. RHT +5%. PNK +5%. SHP +5%.
Losers: ECTE -18%. RIMM -14%. ALU -7%. 1 Comment [On the Move] - Tuesday, November 20, 2012, 6:18 AM ShangPharma (SHP): Q3 EPS of $0.15 misses by $0.05. Revenue of $31.9M (+10.6% Y/Y) misses by $2.1M. (PR) Comment! [Earnings, Healthcare]
- Monday, August 20, 2012, 12:23 PM ShangPharma (SHP -2.4%) slips after missing on its Q2 results earlier today. The company also reconfirms its guidance for net revenues for FY12. Net revenues are expected to be approximately $131.7 to $136.2 million, which represents growth of approximately 18% to 22% compared with FY11. William Blair cuts the shares to Market Perform on the report. Comment! [Earnings, Global & FX, Healthcare, On the Move]
- Monday, August 20, 2012, 7:44 AM ShangPharma (SHP): Q2 EPS of $0.11 misses by $0.09. Revenue of $31.8M (+15.7% Y/Y) misses by $1M. (PR) Comment! [Earnings, Healthcare]
- Friday, July 6, 2012, 8:11 AM Shares of ShangPharma (SHP) move up 15.1% premarket after the firm receives a "going private" buyout offer from a group of private investors at $8.50-$9.50 per ADS. The company says that it's forming a special committee to study the offer. Comment! [M&A, Healthcare]
- Friday, August 12, 2011, 11:02 AM Chinese biotech research firm ShangPharma (SHP +18.3%) pops after announcing a $10M stock repurchase program. In addition, founder and CEO Michael Xin Hui intends to purchase up to $1M worth of its shares through a personal, family-owned company. Comment! [Healthcare, Global & FX, On the Move]